Schraube P, Latz D, Wannenmacher M
Department of Radiotherapy, University of Heidelberg, Germany.
Radiother Oncol. 1994 Dec;33(3):254-8. doi: 10.1016/0167-8140(94)90360-3.
Eleven patients with SCC of the trachea were treated (ten primarily, one postoperatively) with megavolt irradiation (four in combination with brachytherapy). A median survival of 31 and a median disease free survival of 7.5 months was observed. Factors favourable for survival were the achievement of complete remission, the absence of mediastinal lymphnode involvement, and the use of additional brachytherapy.
11例气管鳞状细胞癌患者接受了兆伏放疗（10例为初始治疗，1例为术后治疗）（4例联合近距离放疗）。观察到中位生存期为31个月，中位无病生存期为7.5个月。有利于生存的因素包括实现完全缓解、无纵隔淋巴结受累以及使用额外的近距离放疗。
